TScan Therapeutics (TCRX)
Develops TCR-engineered T-cell therapies for cancer through a T-cell receptor discovery platform.
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 105.74% | 71.67M shares | |
|---|---|---|---|
| 59 holders · as of Jun 30, 2026 | |||
| Insiders | 0.07% | 45.0K shares | |
| 1 holder · as of Sep 24, 2024 | |||
| Strategic holders | 5.32% | 3.60M shares | |
| 1 holder · as of Feb 14, 2025 | |||
| Adds to | 111.13% | ||
67.78M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Two share counts disagree (67.78M in the company's Sep 23, 2026 report, 61.07M elsewhere); stakes use the report.
These groups come from separate filings that can overlap, so they add to 111.13%; nothing is left for Other.
This company has 2 share classes; every stake here is a share of the whole company.
13F, as of Jun 30, 2026
59 holders · 35.84M shares · 8 new positions · 30 increased · 12 reduced · 7 closed
| Holder | Shares | % of company | Chg q/q | Filed |
|---|---|---|---|---|
| LYNX1 Capital Management LP | 8.02M | 11.83% | 0 | Aug 13, 2026 |
| BVF Inc/IL | 5.56M | 8.21% | 0 | Aug 14, 2026 |
| Baker Bros. Advisors LP | 2.78M | 4.11% | 0 | Aug 14, 2026 |
| Vanguard Capital Management LLC | 2.16M | 3.19% | +4.6K | Aug 13, 2026 |
| Two Sigma Investments, LP | 1.95M | 2.88% | +740.6K | Aug 14, 2026 |
| Renaissance Technologies LLC | 1.33M | 1.96% | −38.0K | Aug 13, 2026 |
| Acadian Asset Management LLC | 1.31M | 1.93% | +1.10M | Aug 13, 2026 |
| Deer Management Co. LLC | 1.25M | 1.84% | 0 | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Lynx1 Capital Management LP | 15.00% | 7.86M | 13G | Aug 14, 2025 |
| K2 HealthVentures Equity Trust LLC | 6.90% | 3.60M | 13G | Feb 14, 2025 |
| Biotechnology Value Fund L P | 5.40% | 3.01M | 13G | May 15, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Dec 19, 2025 | Lynx1 Capital Management LP10 percent owner | Purchase | 80,069 | $0.8989 | 7,937,416 |
| Dec 22, 2025 | Lynx1 Capital Management LP10 percent owner | Purchase | 75,500 | $0.9000 | 8,012,916 |
| Dec 23, 2025 | Lynx1 Capital Management LP10 percent owner | Purchase | 6,232 | $0.8989 | 8,019,148 |
House and Senate disclosures
Not reported.